Mohit Kumar Gupta MD, Presenter: Nothing to Disclose

Daniella Ferraro Fernandes Costa Pinho MD, Abstract Co-Author: Nothing to Disclose

April Alexander Bailey MD, Abstract Co-Author: Nothing to Disclose

Gaurav Khatri MD, Abstract Co-Author: Nothing to Disclose

Ivan Pedrosa MD, Abstract Co-Author: Shareholder, Humana Inc

1. To review the types of endoluminal contrast agents available for abdominal and pelvic MRI examinations. 2. To highlight specific clinical scenarios where endoluminal contrast agents help in the identification of abdominal and pelvic pathology. 3. To illustrate how to implement endoluminal contrast agents into clinical abdominal and pelvic MRI protocols.

Endoluminal contrast agents- Water, US gel, Diluted gadolinium, Barium, Iron-based Route of Administration- Endovaginal, endorectal, retrograde transurethral, oral, loopogram, fistulogram Applications of endoluminal contrast - Clarify conventional MRI findings, congenital anomalies, fistula formation, inflammatory bowel disease, extent of pelvic malignancies, endometriosis Use of endoluminal contrast agents in clinical practice - Indications, Selection of contrast agent, Preparation, and MRI Protocol design for specific contrast agents Conclusions - A variety of endoluminal contrast agents are available for clinical use in detecting specific abdominal and pelvic pathology. - Endoluminal contrast agents help identify or accentuate a wide variety of pathologic conditions in the abdomen and pelvis. - Use of endoluminal contrast agents in clinical practice requires understanding specific indications, preparation, and selection of a proper imaging protocol.  

http://abstract.rsna.org/uploads/2014/14003153/14003153_5uc7.pdf

Gupta, M, Pinho, D, Bailey, A, Khatri, G, Pedrosa, I, Endoluminal Contrast for the Abdominal and Pelvic MRI: When, Where, and How?.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14003153.html